These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 18420778)

  • 1. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
    Lebrun C; Debouverie M; Vermersch P; Clavelou P; Rumbach L; de Seze J; Wiertlevski S; Defer G; Gout O; Berthier F; Danzon A
    Mult Scler; 2008 Apr; 14(3):399-405. PubMed ID: 18420778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.
    Achiron A; Barak Y; Gail M; Mandel M; Pee D; Ayyagari R; Rotstein Z
    Breast Cancer Res Treat; 2005 Feb; 89(3):265-70. PubMed ID: 15754125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of disease-modifying treatments in North African migrants with multiple sclerosis in France.
    Lebrun C; Debouverie M; Jeannin S; Pittion-Vouyovitch S; Bayreuther C; Berthier F
    Mult Scler; 2008 Aug; 14(7):933-9. PubMed ID: 18573824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk among patients with multiple sclerosis and their parents.
    Bahmanyar S; Montgomery SM; Hillert J; Ekbom A; Olsson T
    Neurology; 2009 Mar; 72(13):1170-7. PubMed ID: 19332695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
    Le Bouc R; Zéphir H; Majed B; Vérier A; Marcel M; Vermersch P
    Mult Scler; 2012 Jan; 18(1):55-63. PubMed ID: 21844065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer profile in eastern Rajasthan.
    Sharma RG; Ajmera R; Saxena O
    Indian J Cancer; 1994 Sep; 31(3):160-73. PubMed ID: 8557294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis and cancers in Croatia--a possible protective role of the "Mediterranean diet".
    Materljan E; Materljan M; Materljan B; Vlacić H; Barićev-Novaković Z; Sepcić J
    Coll Antropol; 2009 Jun; 33(2):539-45. PubMed ID: 19662776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific immunosuppressants in the treatment of multiple sclerosis.
    Confavreux C; Vukusic S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The cancer registry at the Hôtel Dieu de France Hospital].
    Ghosn M; Tannous R; Gedeon E
    J Med Liban; 1992; 40(1):4-10. PubMed ID: 1339874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.
    Lee KD; Chen SC; Chan CH; Lu CH; Chen CC; Lin JT; Chen MF; Huang SH; Yeh CM; Chen MC
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2647-55. PubMed ID: 18843006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple cancer--an epidemiologic exercise in Finland.
    Teppo L; Pukkala E; Saxén E
    J Natl Cancer Inst; 1985 Aug; 75(2):207-17. PubMed ID: 3860679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Female genital and breast cancers in France: geographic distribution and estimation of incidence].
    Chaplain G; Grosclaude P; Arveux P; Raverdy N; Menegoz F; Henry-Amar M; Schaffer P; Daures JP; de Vathaire F
    Bull Cancer; 1997 Oct; 84(10):935-40. PubMed ID: 9435794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
    J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Descriptive epidemiology of gynecologic and breast cancers].
    Schraub S; Alauzet E; Schaffer P; Robillard J; Menegoz F
    Rev Fr Gynecol Obstet; 1992 Dec; 87(12):577-85. PubMed ID: 1485074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The occurrence of malignancies in a Hungarian lupus population].
    Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study.
    Nielsen NM; Westergaard T; Frisch M; Rostgaard K; Wohlfahrt J; Koch-Henriksen N; Melbye M; Hjalgrim H
    Arch Neurol; 2006 Jul; 63(7):1001-4. PubMed ID: 16831970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
    Cluze C; Delafosse P; Seigneurin A; Colonna M
    Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women.
    Jensen A; Sharif H; Olsen JH; Kjaer SK
    Am J Epidemiol; 2008 Jul; 168(1):49-57. PubMed ID: 18448441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.